We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$9.77M
Cap. Flow
-$5.29M
Cap. Flow %
-2.11%
Top 10 Hldgs %
13.15%
Holding
258
New
40
Increased
80
Reduced
24
Closed
99

Top Buys

Rank Stock Value
1
SSNC icon
SS&C Technologies
SSNC
+$3.13M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.9M
3
VSAT icon
Viasat
VSAT
+$2.05M
4
MTDR icon
Matador Resources
MTDR
+$2.04M
5
MCHP icon
Microchip Technology
MCHP
+$2.03M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$2.89M
2
HUN icon
Huntsman Corp
HUN
+$2.66M
3
PRAA icon
PRA Group
PRAA
+$2.14M
4
WNR
Western Refining Inc
WNR
+$1.97M
5
LOCK
LifeLock, Inc.
LOCK
+$1.94M

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Healthcare 17.12%
3 Consumer Discretionary 12.37%
4 Communication Services 10.85%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATEN icon
101
A10 Networks
ATEN
$2.41B
$1.39M 0.55%
+151,679
New +$1.34M
MNST icon
102
Monster Beverage
MNST
$93.2B
$1.37M 0.55%
59,334
+19,440
+49% +$434K
ANET icon
103
Arista Networks
ANET
$213B
$1.37M 0.54%
165,296
+52,720
+47% +$364K
JAZZ icon
104
Jazz Pharmaceuticals
JAZZ
$16B
$1.33M 0.53%
9,182
+3,456
+60% +$450K
CSGP icon
105
CoStar Group
CSGP
$12.1B
$1.31M 0.52%
+63,160
New +$1.28M
AMRC icon
106
Ameresco
AMRC
$1.11B
$1.31M 0.52%
199,395
+24,673
+14% +$135K
GMED icon
107
Globus Medical
GMED
$10.6B
$1.3M 0.52%
43,779
-20,147
-32% -$550K
IRWD icon
108
Ironwood Pharmaceuticals
IRWD
$650M
$1.29M 0.51%
90,444
+65,793
+267% +$900K
ISRG icon
109
Intuitive Surgical
ISRG
$128B
$1.29M 0.51%
15,174
-297
-2% -$23.5K
SUPN icon
110
Supernus Pharmaceuticals
SUPN
$2.77B
$1.26M 0.5%
+40,359
New +$1.08M
STZ icon
111
Constellation Brands
STZ
$22.2B
$1.25M 0.5%
7,704
– –
CTAS icon
112
Cintas
CTAS
$84.5B
$1.24M 0.5%
39,328
– –
SNPS icon
113
Synopsys
SNPS
$74.9B
$1.24M 0.5%
+17,253
New +$1.15M
CLVS
114
DELISTED
Clovis Oncology, Inc.
CLVS
$1.24M 0.49%
+19,416
New +$1.18M
OMCL icon
115
Omnicell
OMCL
$1.88B
$1.2M 0.48%
29,603
-2,697
-8% -$99.4K
BLK icon
116
Blackrock
BLK
$164B
$1.2M 0.48%
3,133
-1,296
-29% -$496K
UAA icon
117
Under Armour
UAA
$3.02B
$1.2M 0.48%
60,501
+27,971
+86% +$652K
NXTM
118
DELISTED
NxStage Medical Inc.
NXTM
$1.19M 0.48%
+44,491
New +$1.23M
CORT icon
119
Corcept Therapeutics
CORT
$9.7B
$1.19M 0.47%
+108,150
New +$950K
URBN icon
120
Urban Outfitters
URBN
$6.19B
$1.16M 0.46%
48,914
+2,457
+5% +$63.7K
KYNB
121
Kyntra Bio
KYNB
$28.5M
$1.15M 0.46%
1,868
+149
+9% +$90.7K
TXMD icon
122
TherapeuticsMD
TXMD
$24M
$1.13M 0.45%
+3,148
New +$974K
ENSG icon
123
The Ensign Group
ENSG
$10.5B
$1.12M 0.45%
+63,576
New +$1.15M
COST icon
124
Costco
COST
$421B
$1.11M 0.44%
6,615
-1,193
-15% -$200K
DPLO
125
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.08M 0.43%
67,686
+34,918
+107% +$504K
3 4
5
6 7

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return

Capital Impact Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Capital Impact Advisors held 258 positions worth $251M, up 4% from $241M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Capital Impact Advisors's Q1 2017 filing shows 40 new, 80 increased, 24 reduced and 99 closed positions. Its largest new stake was SS&C Technologies: 93,104 shares worth $3.3M. The largest sale was United Therapeutics, an estimated $2.89M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's largest Q1 2017 buy was SS&C Technologies: 93,104 shares worth $3.3M.
  • Capital Impact Advisors added most to Alphabet (Google) Class A in Q1 2017, an estimated $2.9M increase.
  • Capital Impact Advisors's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $2.89M.
  • Capital Impact Advisors fully exited Huntsman Corp in Q1 2017, selling an estimated $2.66M.
  • Capital Impact Advisors's ten largest holdings make up 13% of its $251M portfolio in Q1 2017.
  • Capital Impact Advisors opened 40 new positions and closed 99 in Q1 2017.
  • Capital Impact Advisors's portfolio value rose 4% quarter-over-quarter to $251M.

Based on Capital Impact Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.